US 8003629
21-substituted progesterone derivatives as new antiprogestational agents
granted A61PA61P15/00A61P15/04
Quick answer
US patent 8003629 (21-substituted progesterone derivatives as new antiprogestational agents) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61P, A61P15/00, A61P15/04, A61P15/08, A61P5/24